Digest Network Come funziona
Network
/
Società
Br
Non verificato

Bristol Myers Squibb

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

144 comunicati stampa

Guarda tutti i comunicati
08/06/2026
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
02/06/2026
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
01/06/2026
Cardiologia
Infanzia
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Scienza
Vetrine/Shopping
Giovani
Medicina - Varie
Industria
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
01/06/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
29/05/2026
Eventi
Industria
Scienza
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
27/05/2026
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Eventi
Web e Social Network
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
21/05/2026
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Fiere
Industria
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
20/05/2026
Industria
Scienza
Tecnica
Software
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
08/05/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0
06/05/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Scienza
Farmaceutica
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
Fonte
Bristol Myers Squibb
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0